414 related articles for article (PubMed ID: 28438902)
1. Crucial Role of ROCK2-Mediated Phosphorylation and Upregulation of FHOD3 in the Pathogenesis of Angiotensin II-Induced Cardiac Hypertrophy.
Zhou Q; Wei SS; Wang H; Wang Q; Li W; Li G; Hou JW; Chen XM; Chen J; Xu WP; Li YG; Wang YP
Hypertension; 2017 Jun; 69(6):1070-1083. PubMed ID: 28438902
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II increases secreted frizzled-related protein 5 (sFRP5) expression through AT1 receptor/Rho/ROCK1/JNK signaling in cardiomyocytes.
Jin X; Guo B; Yan J; Yang R; Chang L; Wang Y; Miao C; Liu S; Zhang H; Li Y
Mol Cell Biochem; 2015 Oct; 408(1-2):215-22. PubMed ID: 26126628
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells.
Yamakawa T; Tanaka S; Numaguchi K; Yamakawa Y; Motley ED; Ichihara S; Inagami T
Hypertension; 2000 Jan; 35(1 Pt 2):313-8. PubMed ID: 10642317
[TBL] [Abstract][Full Text] [Related]
4. FHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2.
Okamoto R; Li Y; Noma K; Hiroi Y; Liu PY; Taniguchi M; Ito M; Liao JK
FASEB J; 2013 Apr; 27(4):1439-49. PubMed ID: 23271052
[TBL] [Abstract][Full Text] [Related]
5. Two distinct phosphorylation events govern the function of muscle FHOD3.
Iskratsch T; Reijntjes S; Dwyer J; Toselli P; Dégano IR; Dominguez I; Ehler E
Cell Mol Life Sci; 2013 Mar; 70(5):893-908. PubMed ID: 23052206
[TBL] [Abstract][Full Text] [Related]
6. TMEM16A contributes to angiotensin II-induced cerebral vasoconstriction via the RhoA/ROCK signaling pathway.
Li RS; Wang Y; Chen HS; Jiang FY; Tu Q; Li WJ; Yin RX
Mol Med Rep; 2016 Apr; 13(4):3691-9. PubMed ID: 26955761
[TBL] [Abstract][Full Text] [Related]
7. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy.
Hingtgen SD; Tian X; Yang J; Dunlay SM; Peek AS; Wu Y; Sharma RV; Engelhardt JF; Davisson RL
Physiol Genomics; 2006 Aug; 26(3):180-91. PubMed ID: 16670255
[TBL] [Abstract][Full Text] [Related]
8. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II induces reorganization of the actin cytoskeleton and myosin light-chain phosphorylation in podocytes through rho/ROCK-signaling pathway.
Wang S; Chen C; Su K; Zha D; Liang W; Hillebrands JL; Goor Hv; Ding G
Ren Fail; 2016; 38(2):268-75. PubMed ID: 26652313
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin inhibits angiotensin II-induced cardiac cell hypertrophy: role of Homer 1a.
Guo WG; Su FF; Yuan LJ; Yang GD; Shi XQ; Li RY; Shu Q; Liu XT; Lu ZF; Zheng QS
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):40-5. PubMed ID: 19515066
[TBL] [Abstract][Full Text] [Related]
11. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
Aoki H; Richmond M; Izumo S; Sadoshima J
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II Facilitates Matrix Metalloproteinase-9-Mediated Myosin Light Chain Kinase Degradation in Pressure Overload-Induced Cardiac Hypertrophy.
Wang S; Cheng M; Hu Z; Hu S; Zou Q; Lai X; Liu B; Jiang H; Huang C; Wu G
Cell Physiol Biochem; 2017; 44(6):2281-2295. PubMed ID: 29262413
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide inhibits endothelin-1-induced neonatal cardiomyocyte hypertrophy via a RhoA-ROCK-dependent pathway.
Hunter JC; Zeidan A; Javadov S; Kilić A; Rajapurohitam V; Karmazyn M
J Mol Cell Cardiol; 2009 Dec; 47(6):810-8. PubMed ID: 19799911
[TBL] [Abstract][Full Text] [Related]
14. Kamolonol suppresses angiotensin II-induced stress fiber formation and cellular hypertrophy through inhibition of Rho-associated kinase 2 activity.
Kim MS; Oh KS; Lee JH; Ryu SY; Mun J; Lee BH
Biochem Biophys Res Commun; 2013 Aug; 438(2):318-23. PubMed ID: 23891689
[TBL] [Abstract][Full Text] [Related]
15. Shen'ge powder decreases the cardiomyocyte hypertrophy in chronic heart failure by activating the Rho protein/Rho-associated coiledcoil forming protein kinase signaling pathway.
Yan X; Jiao K; Song X
J Cell Biochem; 2019 Mar; 120(3):3038-3045. PubMed ID: 30474257
[TBL] [Abstract][Full Text] [Related]
16. A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes.
Lyu L; Wang H; Li B; Qin Q; Qi L; Nagarkatti M; Nagarkatti P; Janicki JS; Wang XL; Cui T
J Mol Cell Cardiol; 2015 Dec; 89(Pt B):268-79. PubMed ID: 26497614
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of Nox4 promotes angiotensin II-induced epidermal growth factor receptor activation and subsequent cardiac hypertrophy by increasing ADAM17 expression.
Zeng SY; Chen X; Chen SR; Li Q; Wang YH; Zou J; Cao WW; Luo JN; Gao H; Liu PQ
Can J Cardiol; 2013 Oct; 29(10):1310-9. PubMed ID: 23850346
[TBL] [Abstract][Full Text] [Related]
18. Role of myofibrillogenesis regulator-1 in myocardial hypertrophy.
Liu X; Li T; Sun S; Xu F; Wang Y
Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H279-85. PubMed ID: 16100249
[TBL] [Abstract][Full Text] [Related]
19. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
Yu L; Meng W; Ding J; Cheng M
Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II type-1 receptor-JAK/STAT pathway mediates the induction of visfatin in angiotensin II-induced cardiomyocyte hypertrophy.
Chang L; Yang R; Wang M; Liu J; Wang Y; Zhang H; Li Y
Am J Med Sci; 2012 Mar; 343(3):220-6. PubMed ID: 21841463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
